Glucocorticoids in Early Rheumatoid Arthritis: Are the Benefits of Joint-Sparing Effects Offset by the Adverse Effect of Osteoporosis? The Effects on Bone in the Utrecht Study and the CAMERA-II Study.

J.W.G. Jacobs; J.W.J. Bijlsma; J.M. van Laar

doi:10.1159/000362729

Glucocorticoids in Early Rheumatoid Arthritis: Are the Benefits of Joint-Sparing Effects Offset by the Adverse Effect of Osteoporosis? The Effects on Bone in the Utrecht Study and the CAMERA-II Study.

J.W.G. Jacobs
, J.W.J. Bijlsma
, J.M. van Laar

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	66-71
Number of pages	6
Journal	NeuroImmunoModulation
Volume	22
Issue number	1-2
DOIs	https://doi.org/10.1159/000362729
Publication status	Published - 2014

Access to Document

10.1159/000362729

Cite this

@article{abd4e60665244268a78a82f1d4eb040c,

title = "Glucocorticoids in Early Rheumatoid Arthritis: Are the Benefits of Joint-Sparing Effects Offset by the Adverse Effect of Osteoporosis? The Effects on Bone in the Utrecht Study and the CAMERA-II Study.",

author = "J.W.G. Jacobs and J.W.J. Bijlsma and \{van Laar\}, J.M.",

year = "2014",

doi = "10.1159/000362729",

language = "English",

volume = "22",

pages = "66--71",

journal = "NeuroImmunoModulation",

issn = "1021-7401",

publisher = "S. Karger AG",

number = "1-2",

}

Glucocorticoids in Early Rheumatoid Arthritis: Are the Benefits of Joint-Sparing Effects Offset by the Adverse Effect of Osteoporosis? The Effects on Bone in the Utrecht Study and the CAMERA-II Study. / Jacobs, J.W.G.; Bijlsma, J.W.J.; van Laar, J.M.
In: NeuroImmunoModulation, Vol. 22, No. 1-2, 2014, p. 66-71.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Glucocorticoids in Early Rheumatoid Arthritis: Are the Benefits of Joint-Sparing Effects Offset by the Adverse Effect of Osteoporosis? The Effects on Bone in the Utrecht Study and the CAMERA-II Study.

AU - Jacobs, J.W.G.

AU - Bijlsma, J.W.J.

AU - van Laar, J.M.

PY - 2014

Y1 - 2014

U2 - 10.1159/000362729

DO - 10.1159/000362729

M3 - Article

C2 - 25228126

SN - 1021-7401

VL - 22

SP - 66

EP - 71

JO - NeuroImmunoModulation

JF - NeuroImmunoModulation

IS - 1-2

ER -